UnitedHealth Group Files 8-K for Financial Reporting

TL;DR

UNH filed an 8-K for financial statements & exhibits - standard disclosure.

AI Summary

On July 23, 2024, UnitedHealth Group Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update or disclosure related to the company's financial reporting. No specific material events or transactions were detailed in the provided excerpt.

Why It Matters

This filing serves as a standard disclosure for UnitedHealth Group, providing investors with updated financial information and exhibits as required by the SEC.

Risk Assessment

Risk Level: low — The filing appears to be a routine disclosure of financial statements and exhibits, not indicating any new or unusual risks.

Key Players & Entities

• UNITEDHEALTH GROUP INC (company) — Registrant
• 0000731766-24-000255 (document_id) — Accession Number
• July 23, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $500,000,000 — 26 in the aggregate principal amount of $500,000,000, (ii) 4.750% Notes due July 15, 2026 in
• $650,000,000 — 26 in the aggregate principal amount of $650,000,000, (iii) 4.800% Notes due January 15, 203
• $1,250,000,000 — 30 in the aggregate principal amount of $1,250,000,000, (iv) 4.950% Notes due January 15, 2032
• $1,500,000,000 — 32 in the aggregate principal amount of $1,500,000,000, (v) 5.150% Notes due July 15, 2034 in
• $2,000,000,000 — 34 in the aggregate principal amount of $2,000,000,000, (vi) 5.500% Notes due July 15, 2044 in
• $2,750,000,000 — 54 in the aggregate principal amount of $2,750,000,000 and (viii) 5.750% Notes due July 15, 20
• $1,850,000,000 — 64 in the aggregate principal amount of $1,850,000,000 (collectively, the "Notes"), pursuant t

Filing Documents

• unh-20240723.htm (8-K) — 46KB
• ex11unh-underwritingagreem.htm (EX-1.1) — 139KB
• ex12unh-pricingagreement20.htm (EX-1.2) — 254KB
• ex41unh-2026floatingrateno.htm (EX-4.1) — 222KB
• ex42unh-2026fixedratenotes.htm (EX-4.2) — 159KB
• ex43unh-2030fixedratenotes.htm (EX-4.3) — 162KB
• ex44-unhx2032fixedratenote.htm (EX-4.4) — 150KB
• ex45-unhx2034fixedratenote.htm (EX-4.5) — 150KB
• ex46-unhx2044fixedratenote.htm (EX-4.6) — 150KB
• ex47unh-2054fixedratenotes.htm (EX-4.7) — 147KB
• ex48unh-2064fixedratenotes.htm (EX-4.8) — 147KB
• ex51unh-opinionjuly2024.htm (EX-5.1) — 15KB
• image_0a.jpg (GRAPHIC) — 4KB
• 0000731766-24-000255.txt ( ) — 2199KB
• unh-20240723.xsd (EX-101.SCH) — 2KB
• unh-20240723_def.xml (EX-101.DEF) — 14KB
• unh-20240723_lab.xml (EX-101.LAB) — 25KB
• unh-20240723_pre.xml (EX-101.PRE) — 15KB
• unh-20240723_htm.xml (XML) — 3KB

01. Other Events

Item 8.01. Other Events. On July 23, 2024, UnitedHealth Group Incorporated (the "Company") agreed to sell its (i) Floating Rate Notes due July 15, 2026 in the aggregate principal amount of $500,000,000, (ii) 4.750% Notes due July 15, 2026 in the aggregate principal amount of $650,000,000, (iii) 4.800% Notes due January 15, 2030 in the aggregate principal amount of $1,250,000,000, (iv) 4.950% Notes due January 15, 2032 in the aggregate principal amount of $1,500,000,000, (v) 5.150% Notes due July 15, 2034 in the aggregate principal amount of $2,000,000,000, (vi) 5.500% Notes due July 15, 2044 in the aggregate principal amount of $1,500,000,000, (vii) 5.625% Notes due July 15, 2054 in the aggregate principal amount of $2,750,000,000 and (viii) 5.750% Notes due July 15, 2064 in the aggregate principal amount of $1,850,000,000 (collectively, the "Notes"), pursuant to the Underwriting Agreement, dated July 23, 2024 (the "Underwriting Agreement"), and the Pricing Agreement, dated July 23, 2024 (the "Pricing Agreement"), both among the Company and Wells Fargo Securities, LLC, Citigroup Global Markets Inc., J.P. Morgan Securities LLC, PNC Capital Markets LLC, RBC Capital Markets, LLC and U.S. Bancorp Investments, Inc., as representatives of the several underwriters listed in Schedule I to the Pricing Agreement. The Notes were issued on July 25, 2024 pursuant to the Indenture, dated as of February 4, 2008, between the Company and U.S. Bank Trust Company, National Association, as trustee (the "Indenture"), and the Officers' Certificates and Company Orders, each dated July 25, 2024, relating to each series of the Notes, in each case, pursuant to Sections 201, 301 and 303 of the Indenture. The Notes have been registered under the Securities Act of 1933, as amended, pursuant to the Company's automatic shelf registration statement on Form S-3, File No. 333-270279 (the "Registration Statement"). The Company is filing this Current Report on Form 8-K to file with the Securities a

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 1.1 Underwriting Agreement, dated July 23, 2024, among the Company and Wells Fargo Securities, LLC, Citigroup Global Markets Inc., J.P. Morgan Securities LLC, PNC Capital Markets LLC, RBC Capital Markets, LLC and U.S. Bancorp Investments, Inc., as Representatives of the several Underwriters 1.2 Pricing Agreement, dated July 23, 2024, among the Company and Wells Fargo Securities, LLC, Citigroup Global Markets Inc., J.P. Morgan Securities LLC, PNC Capital Markets LLC, RBC Capital Markets, LLC and U.S. Bancorp Investments, Inc., as Representatives of the several Underwriters 4.1 Officers' Certificate and Company Order, dated July 25, 2024, relating to the Floating Rate Notes due July 15, 2026, pursuant to Sections 201, 301 and 303 of the Indenture (including the form of Floating Rate Notes due July 15, 2026) 4.2 Officers' Certificate and Company Order, dated July 25, 2024, relating to the 4.750% Notes due July 15, 2026, pursuant to Sections 201, 301 and 303 of the Indenture (including the form of 4.750% Notes due July 15, 2026) 4.3 Officers' Certificate and Company Order, dated July 25, 2024, relating to the 4.800% Notes due January 15, 2030, pursuant to Sections 201, 301 and 303 of the Indenture (including the form of 4.800% Notes due January 15, 2030) 4.4 Officers' Certificate and Company Order, dated July 25, 2024, relating to the 4.950% Notes due January 15, 2032, pursuant to Sections 201, 301 and 303 of the Indenture (including the form of 4.950% Notes due January 15, 2032) 4.5 Officers' Certificate and Company Order, dated July 25, 2024, relating to the 5.150% Notes due July 15, 2034, pursuant to Sections 201, 301 and 303 of the Indenture (including the form of 5.150% Notes due July 15, 2034) 4.6 Officers' Certificate and Company Order, dated July 25, 2024, relating to the 5.500% Notes due July 15, 2044, pursuant to Sections 201, 301 and 303 of the Indenture

Signatures

Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 25, 2024 UNITEDHEALTH GROUP INCORPORATED By: /s/ Kuai H. Leong Name: Kuai H. Leong Title: Senior Deputy General Counsel and Deputy Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR